Hemogenyx Pharmaceuticals have filed for permission to treat children with AML, their ongoing HG-CT-1 is with MDA. The company could seriously do with assistance funding these trials. Company have been shorted making it almost impossible to raise reasonable levels of funding.

Hi, do you see replies? Are you aware that Hemogenyx, sponsor of your HG-CT-1 trial are under a short attack from a well known trader accusing them of lying about the trial? At 12m mCap they are vulnerable. Any sort of coverage, even a tweet would help naming them.

I hope Hemogenyx and HG-CT-1 will be part of the story treating pediatric patients with MD Anderson ❤️

We need Chimeric Bait Receptor Platform from Hemogenyx.

More interested in the Chimeric Bait Receptor Platform from Hemogenyx, why not partner/ fund research there??

Evening for you is 9-5 somewhere in the world.....

Can I suggest you checkout HG-CT-1, then look at their CDX and CBR treatment, extremely exciting but very early!

Hi, first CAR-T post I have seen on blue sky, moving from twitter. Have you seen HG-CT-1 from Hemogenyx, trials to be launched this week, company very under the radar,worth covering. Initially AML however also targeting ALL and with their bispecific Lupus aswell!